Source: https://www.law.cornell.edu/cfr/text/21/1311.102
Timestamp: 2016-07-26 16:07:30
Document Index: 277378239

Matched Legal Cases: ['art 1311', '§ 1311', '§ 1311', '§ 1311', '§ 1311', '§ 1306', '§ 1311', '§ 1306', '§ 1311', '§ 1311', '§ 1311', '§ 1311']

21 CFR 1311.102 - Practitioner responsibilities. | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter II › Part 1311 › Subpart C › Section 1311.102 21 CFR 1311.102 - Practitioner responsibilities.
§ 1311.102 Practitioner responsibilities.
(b) The practitioner must notify the individuals designated under § 1311.125 or § 1311.130 within one business day of discovery that the hard token has been lost, stolen, or compromised or the authentication protocol has been otherwise compromised. A practitioner who fails to comply with this provision may be held responsible for any controlled substance prescriptions written using his two-factor authentication
(c) If the practitioner is notified by an intermediary or pharmacy that an electronic prescription was not successfully delivered, as provided in § 1311.170, he must ensure that any paper or oral prescription (where permitted) issued as a replacement of the original electronic prescription indicates that the prescription was originally transmitted electronically to a particular pharmacy and that the transmission failed.
(1) The information required for a prescription under § 1306.05(a) of this chapter.
(2) The indication of signing as required by § 1311.120(b)(17) or the digital signature created by the practitioner's private key.
(3) The number of refills as required by § 1306.22 of this chapter.
(2) Ensure, for an installed electronic prescription application at an individual practitioner's practice, that the individuals designated under § 1311.125 terminate access for signing controlled substance prescriptions.
(h) If an electronic prescription application provider notifies an institutional practitioner that a third-party audit or certification report indicates that the application or the application provider no longer meets the requirements of this part or notifies it that the application provider has identified an issue that makes the application non-compliant, the institutional practitioner must ensure that the individuals designated under § 1311.130 terminate access for signing controlled substance prescriptions.
(j) The practitioner must notify both the individuals designated under § 1311.125 or § 1311.130 and the Administration within one business day of discovery that one or more prescriptions that were issued under a DEA registration held by that practitioner were prescriptions the practitioner had not signed or were not consistent with the prescriptions he signed.